Morgan Stanley initiated coverage of Accelerant (ARX) with an Equal Weight rating and $28 price target The firm says the company is benefitting from the shift of risk into specialty markets with a risk exchange platform. However, Accelerant’s current valuation reflects most of its growth opportunities, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant Holdings Class A: Strong Buy Rating Driven by Strategic Positioning and Growth Potential in Specialty Insurance
- Accelerant initiated with an Outperform at RBC Capital
- Accelerant initiated with an Overweight at Piper Sandler
- Accelerant initiated with a Market Perform at Citizens JMP
- Accelerant initiated with a Neutral at Goldman Sachs